PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,696 | +101.4% | 9,766 | +150.9% | 0.00% | – |
Q2 2023 | $6,305 | -79.7% | 3,892 | -90.5% | 0.00% | – |
Q3 2022 | $31,000 | -32.6% | 41,126 | -30.5% | 0.00% | – |
Q2 2022 | $46,000 | +21.1% | 59,176 | +40.3% | 0.00% | – |
Q1 2022 | $38,000 | -90.5% | 42,167 | -15.8% | 0.00% | – |
Q4 2021 | $401,000 | +5628.6% | 50,102 | +5929.1% | 0.00% | – |
Q3 2021 | $7,000 | -93.9% | 831 | -95.1% | 0.00% | – |
Q2 2021 | $114,000 | +225.7% | 16,898 | +196.5% | 0.00% | – |
Q2 2020 | $35,000 | +12.9% | 5,700 | +1.4% | 0.00% | – |
Q1 2020 | $31,000 | -90.2% | 5,620 | -82.4% | 0.00% | -100.0% |
Q4 2019 | $316,000 | +572.3% | 31,904 | +292.9% | 0.00% | – |
Q3 2019 | $47,000 | – | 8,120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |